Comparative Analysis of Deep Learning Architectures for Multi-Disease Classification of Single-Label Chest X-rays
Authors: Ali M. Bahram, Saman Muhammad Omer, Hardi M. Mohammed
Organizations: Department of Computer Science, College of Science, Charmo University, 46023 Chamchamal, Kurdistan Region, Iraq · Department of Software Engineering, University of Raparin, Ranya, Kurdistan Region, Iraq
Chest X-ray imaging remains the primary diagnostic tool for pulmonary and cardiac disorders worldwide, yet its accuracy is hampered by radiologist shortages and inter-observer variability. This study presents a systematic comparative evaluation of seven deep learning architectures for multi-class chest disease classification: ConvNeXt-Tiny, DenseNet121, DenseNet201, ResNet50, ViT-B/16, EfficientNetV2-M, and MobileNetV2. A balanced dataset of 18,080 chest X-ray images spanning five disease categories (Cardiomegaly, COVID-19, Normal, Pneumonia, and Tuberculosis) was constructed from three public repositories and partitioned at the patient level to prevent data leakage. All models were trained under identical conditions using ImageNet-pretrained weights, standardized preprocessing, and consistent hyperparameters. All seven architectures exceeded 90% test accuracy. ConvNeXt-Tiny achieved the highest performance (92.31% accuracy, 95.70% AUROC), while MobileNetV2 emerged as the most parameter-efficient model (3.5M parameters, 90.42% accuracy, 94.10% AUROC), completing training in 48 minutes. Tuberculosis and COVID-19 classification was near-perfect (AUROC >= 99.97%) across all architectures, while Normal, Cardiomegaly, and Pneumonia presented greater challenges due to overlapping radiographic features. Grad-CAM visualizations confirmed clinically consistent attention patterns across disease categories. These findings demonstrate that high-accuracy multi-disease chest X-ray classification is achievable without excessive computational resources, with important implications for AI-assisted diagnosis in both resource-rich and resource-constrained healthcare settings.
COVID-19 was a significant challenge that led to the loss of numerous lives daily. Not only a certain country was involved in this outbreak, but even the world has suffered because of the coronavirus. Imaging techniques using computed tomography (CT) and X-rays of the lungs are the most useful tools for the COVID-19 or any other pandemic disease screening process. Technology today has revolutionized the world by using artificial intelligence to replace manual processes with automated machines, which enable the system to imitate the human brain by making wise decisions based on experience. Motivated by this, our work proposes to use convolutional neural networks (CNN) based models for designing a computer-aided diagnosis (CAD) system that differentiates between COVID-19 and healthy lung pictures. We used two different sets of X-ray images of the lungs in addition to two different sets of CT scans and the classification is done using a variety of networks that have been pre-trained such as VGG (16, 19), Densenet (121), Resnet (50, 50 V2, 101 V2), Mobile net (V2), Xception Inception (V3, Resnet V2), Efficient net (B0) and Nasnet (Large). On the X-ray and CT image datasets, Resnet and VGG architecture have shown the ability to properly differentiate COVID-19 from normal images, with an average accuracy of 95 to 98 percent respectively. Our acquired results on the classification datasets are competitive and superior to previously reported findings in the literature.
Sarmad Khan, Arslan Shaukat, Umer Asgher +1
Department of Computer & Software Engineering National University of Sciences & Technology Islamabad, Pakistan · School of Computing & Information Systems University of Melbourne Melbourne, Australia
With the increase in the number of cases related to respiratory diseases, there is an urgent need to detect them early and diagnose them accurately. Convolutional neural networks have given promising results when used for diagnosing diseases using imaging tests. In this study, we investigate the potential of applying deep learning algorithms such as VGG16, VGG19, and ResNet50 for classification of lung ailments based on X-ray images. A detailed analysis of the aforementioned models' performances was conducted to assess how well they can classify various types of lung ailments, including pneumonia, tuberculosis, lung cancer, and normal lungs. In order to do that, these deep learning models were trained on a vast amount of X-ray images. The results of our study show that while all three models provide good results, ResNet-50 performs best in comparison with other models due to its efficiency and high level of accuracy. We believe that these deep learning models can be successfully implemented in the practice of diagnosing pulmonary diseases in the future. It helps with early disease detection and improves patient outcomes.
Nand Lal Yadav, Rajesh Kumar, Satyendra Singh +1
Department of Electronics and Communication, University of Allahabad, Prayagraj, India.
Automated classification of pulmonary disease from chest radiographs is a widely studied application of machine learning in medical imaging. This paper presents a pilot study evaluating classical texture- and gradient-based feature representations for distinguishing COVID-19 from other forms of pneumonia using the publicly available COVID-19 Image Data Collection (668 posteroanterior/anteroposterior radiographs from 408 patients). Using histogram of oriented gradients (HOG) and gray-level co-occurrence matrix (GLCM) texture descriptors with classical classifiers (logistic regression, random forest, and support vector machine), evaluated under patient-level 5-fold stratified cross-validation to prevent data leakage, we obtain a best mean accuracy of 75.4% and AUC of 0.755, modestly exceeding the 71.6% majority-class baseline. We report these results transparently, including their limitations, and use them to motivate and scope a proposed multi-modal deep learning architecture -- combining convolutional and transformer-based encoders across imaging modalities -- as a direction for future work requiring access to larger, multi-institutional, ethically sourced datasets.